Key Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$387K Buy
917
+4
+0.4% +$1.59K 0.14% 100
2026
Q2
$331K Buy
913
+2
+0.2% +$685 0.17% 63
2026
Q1
$321K Buy
911
+460
+102% +$164K 0.21% 53
2025
Q4
$148K Buy
+451
New +$143K 0.15% 73

Other funds holding AMGN

Key Capital Management's AMGN Position: Q3 2026 in Review

Key Capital Management increased its Amgen (AMGN) stake by 0.44% in Q3 2026, buying an estimated $1.59K and bringing the position to 917 shares worth $387K. The position accounts for 0.14% of the portfolio, ranked #100.

Key Capital Management first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 2,162 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Key Capital Management held 917 shares of Amgen worth $387K as of Q3 2026.
  • Key Capital Management bought 4 Amgen shares in Q3 2026, an estimated $1.59K.
  • Amgen made up 0.14% of Key Capital Management's portfolio in Q3 2026, its #100 holding.
  • Key Capital Management first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • 2,162 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Key Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.